ARTICLE | Clinical News
2B3-201: Phase I started
December 23, 2013 8:00 AM UTC
to-BBB began a double-blind, crossover, Dutch Phase I trial to evaluate single ascending-doses of 2B3-201 in about 18 healthy volunteers. Subjects will each receive an infusion of 2B3-201, placebo and...